You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?
|
|---|---|
| Published in |
Frontiers in immunology, October 2017
|
| DOI | 10.3389/fimmu.2017.01245 |
| Pubmed ID | |
| Authors |
Michael J. E. Marshall, Richard J. Stopforth, Mark S. Cragg |
X Demographics
The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 2 | 13% |
| Australia | 1 | 7% |
| United States | 1 | 7% |
| Mexico | 1 | 7% |
| Colombia | 1 | 7% |
| Switzerland | 1 | 7% |
| Unknown | 8 | 53% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 12 | 80% |
| Scientists | 2 | 13% |
| Practitioners (doctors, other healthcare professionals) | 1 | 7% |
Mendeley readers
The data shown below were compiled from readership statistics for 212 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 212 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 40 | 19% |
| Student > Bachelor | 29 | 14% |
| Student > Master | 26 | 12% |
| Researcher | 22 | 10% |
| Student > Doctoral Student | 14 | 7% |
| Other | 28 | 13% |
| Unknown | 53 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 40 | 19% |
| Medicine and Dentistry | 32 | 15% |
| Agricultural and Biological Sciences | 25 | 12% |
| Immunology and Microbiology | 20 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 13 | 6% |
| Other | 24 | 11% |
| Unknown | 58 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 June 2021.
All research outputs
#2,209,234
of 26,017,215 outputs
Outputs from Frontiers in immunology
#2,169
of 32,223 outputs
Outputs of similar age
#41,614
of 334,345 outputs
Outputs of similar age from Frontiers in immunology
#50
of 540 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,223 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 334,345 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 540 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.